The U.S. Food and Drug Administration has approved gatifloxacin (
Zymar®,
Zymaxid™) to treat bacterial cases of
pink eye (known medically as conjunctivitis). This condition is characterized by inflammation of the conjunctiva, which is the thin membrane that lines the whites of the eyes and the inner eyelids.
Gatifloxacin is available as an ophthalmic solution (eye drop) and is applied to the affected eye two to eight times a day for seven days. The exact course of treatment your healthcare provider recommends will depend on the severity of your infection, among other things.
(Click Gatifloxacin for more information on this ophthalmic solution, including how it works, important safety precautions, and side effect to watch for during treatment.)
HealthSavvy Sign In
|